Reported value$254K14,000 shares at $18.12
For this personNormal for them6 buys · 1 sale on file
Similar buys beat S&P48%583 cases · all buys 46%
Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Raised their own holding by 933%.
- Similar past buys beat the S&P 500 48% of the time (583 cases), above the 46% for all buys.
- Their past buys: 2 of 3 beat the S&P 500 over 90 days.
Reasons for caution
- Other insiders sold $481K in the same 90 days, more than was bought.
What happened after this filing
7 days
Pending
due Nov 4
30 days
Pending
due Nov 27
90 days
Pending
due Jan 26
Insider Twins: past buys with the same traits
1 insider buying · no CEO or CFO · $250K–$1M · stock down 0–20% in 3 months
AGL Mar 3, 2026 +541.0% vs S&PFUBO Sep 28, 2020 +370.9% vs S&PMRNA Feb 18, 2020 +334.9% vs S&PASPU Oct 4, 2021 -70.5% vs S&PEOLS Aug 31, 2021 -52.3% vs S&PMDIA Feb 11, 2022 -49.9% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Summary
James D Rollins III (a director) bought $254K of HBAN at about $18.12 on Oct 26, 2026, reported to the SEC on Oct 28, 2026. Buys like this beat the S&P 500 48% of the time since 2020, against 46% for all insider buys. We found 4 points that make it worth a closer look and 1 reason for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the HBAN alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.